Concurrent Investment Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.03M Sell
18,364
-2,596
-12% -$932K 0.07% 315
2025
Q4
$7.37M Buy
20,960
+5,628
+37% +$2.05M 0.08% 250
2025
Q3
$5.67M Sell
15,332
-294
-2% -$114K 0.1% 218
2025
Q2
$6.18M Buy
15,626
+750
+5% +$281K 0.12% 184
2025
Q1
$5.54M Buy
14,876
+6,301
+73% +$2.4M 0.13% 164
2024
Q4
$3.09M Buy
8,575
+1,040
+14% +$385K 0.08% 242
2024
Q3
$2.72M Sell
7,535
-1,179
-14% -$407K 0.08% 238
2024
Q2
$2.96M Buy
8,714
+1,016
+13% +$344K 0.1% 212
2024
Q1
$2.75M Buy
7,698
+164
+2% +$55.2K 0.11% 190
2023
Q4
$2.26M Buy
+7,534
New +$2.11M 0.11% 206

Other funds holding SYK

Concurrent Investment Advisors's SYK Position: Q1 2026 in Review

Concurrent Investment Advisors reduced its Stryker (SYK) stake by 12% in Q1 2026, selling an estimated $932K and leaving 18,364 shares worth $6.03M. The position accounts for 0.07% of the portfolio, ranked #315.

Concurrent Investment Advisors first reported a position in SYK in Q4 2023 and has held it in 10 quarters since. The position peaked at $7.37M in Q4 2025. 2,294 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Concurrent Investment Advisors held 18,364 shares of Stryker worth $6.03M as of Q1 2026.
  • Concurrent Investment Advisors sold 2,596 Stryker shares in Q1 2026, an estimated $932K.
  • Stryker made up 0.07% of Concurrent Investment Advisors's portfolio in Q1 2026, its #315 holding.
  • Concurrent Investment Advisors first reported a position in Stryker in Q4 2023 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's Stryker position peaked at $7.37M in Q4 2025.
  • 2,294 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.